ACLY and cryopyrin-associated periodic syndrome: Biologically, according to the CAPS Registry, LA was found in 83% of proven CAPS cases, aCL IgG in 81%, aCL IgM in 49%, anti-β2-GP1 IgG in 78%, and anti-β2GP1 IgM in 40% of cases [10] (Table S1).